 | • レポートコード：QYR2104Z3134 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、点頭てんかん治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・点頭てんかん治療の市場動向 ・企業の競争状況、市場シェア ・点頭てんかん治療の種類別市場規模（経口、注射） ・点頭てんかん治療の用途別市場規模（病院、クリニック） ・点頭てんかん治療の北米市場規模2016-2027（アメリカ、カナダ） ・点頭てんかん治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・点頭てんかん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・点頭てんかん治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・点頭てんかん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Mallinckrodt、H. Lundbeck、Insys Therapeutics、Orphelia Pharma、Valerion Therapeutics、Catalyst Pharmaceuticals、Anavex Life Sciences、Retrophin、GW Pharmaceuticals） ・結論 |
An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.
The global infantile spasms therapeutics market is growing at a slow pace. This is due to the increased availability of generic drugs and less approved therapies in the market and the less awareness of the disease and the available treatment options, especially in the low- and middle-income countries.
The classification of Infantile Spasms Therapeutics includes Oral, Injection. The proportion of Injection in 2016 is about 45%, and the proportion of Oral in 2016 is about 55%.
Based on application, the nitinol medical devices market is segmented into Hospital, Clinic and others. Clinic segment accounted for larger market share in terms of sales in 2016, Clinic segmented accounted for more than 45% of the market share in 2016.
United States is the largest consumption place, with a consumption market share nearly 83% in 2016. Following United States, Europe is the second largest consumption place with the consumption market share of 12.6% in 2016.
The US market is dominated by two approved products H.P. Acthar Gel (adrenocorticotropin hormone) and Sabril (vigabatrin). Sabril was the first drug to be approved by the Food and Drug Administration (FDA) in 2009 and H.P. Acthar Gel (adrenocorticotropin hormone) was approved for infantile spasms in 2010. Both have Orphan Drug Exclusivity (ODE) in the US.
In the future, the Infantile Spasms Therapeutics will have a good future; the price fluctuation has relationship with the raw material. The technology will more mature and the industry is more dispersion.
Market Analysis and Insights: Global Infantile Spasms Therapeutics Market
The global Infantile Spasms Therapeutics market size is projected to reach US$ 178.4 million by 2026, from US$ 138.9 million in 2019, at a CAGR of 3.6% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Infantile Spasms Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Infantile Spasms Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Infantile Spasms Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Infantile Spasms Therapeutics market.
Global Infantile Spasms Therapeutics Scope and Market Size
Infantile Spasms Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Infantile Spasms Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Oral
Injection
Segment by Application
Hospital
Clinic
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Mallinckrodt
H. Lundbeck
Insys Therapeutics
Orphelia Pharma
Valerion Therapeutics
Catalyst Pharmaceuticals
Anavex Life Sciences
Retrophin
GW Pharmaceuticals
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infantile Spasms Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Infantile Spasms Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Infantile Spasms Therapeutics Market Perspective (2016-2027)
2.2 Infantile Spasms Therapeutics Growth Trends by Regions
2.2.1 Infantile Spasms Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Infantile Spasms Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Infantile Spasms Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Infantile Spasms Therapeutics Industry Dynamic
2.3.1 Infantile Spasms Therapeutics Market Trends
2.3.2 Infantile Spasms Therapeutics Market Drivers
2.3.3 Infantile Spasms Therapeutics Market Challenges
2.3.4 Infantile Spasms Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infantile Spasms Therapeutics Players by Revenue
3.1.1 Global Top Infantile Spasms Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Infantile Spasms Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Infantile Spasms Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Infantile Spasms Therapeutics Revenue
3.4 Global Infantile Spasms Therapeutics Market Concentration Ratio
3.4.1 Global Infantile Spasms Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infantile Spasms Therapeutics Revenue in 2020
3.5 Infantile Spasms Therapeutics Key Players Head office and Area Served
3.6 Key Players Infantile Spasms Therapeutics Product Solution and Service
3.7 Date of Enter into Infantile Spasms Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Infantile Spasms Therapeutics Breakdown Data by Type
4.1 Global Infantile Spasms Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Infantile Spasms Therapeutics Forecasted Market Size by Type (2022-2027)
5 Infantile Spasms Therapeutics Breakdown Data by Application
5.1 Global Infantile Spasms Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Infantile Spasms Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Infantile Spasms Therapeutics Market Size (2016-2027)
6.2 North America Infantile Spasms Therapeutics Market Size by Type
6.2.1 North America Infantile Spasms Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Infantile Spasms Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Infantile Spasms Therapeutics Market Size by Type (2016-2027)
6.3 North America Infantile Spasms Therapeutics Market Size by Application
6.3.1 North America Infantile Spasms Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Infantile Spasms Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Infantile Spasms Therapeutics Market Size by Application (2016-2027)
6.4 North America Infantile Spasms Therapeutics Market Size by Country
6.4.1 North America Infantile Spasms Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Infantile Spasms Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Infantile Spasms Therapeutics Market Size (2016-2027)
7.2 Europe Infantile Spasms Therapeutics Market Size by Type
7.2.1 Europe Infantile Spasms Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Infantile Spasms Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Infantile Spasms Therapeutics Market Size by Type (2016-2027)
7.3 Europe Infantile Spasms Therapeutics Market Size by Application
7.3.1 Europe Infantile Spasms Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Infantile Spasms Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Infantile Spasms Therapeutics Market Size by Application (2016-2027)
7.4 Europe Infantile Spasms Therapeutics Market Size by Country
7.4.1 Europe Infantile Spasms Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Infantile Spasms Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Infantile Spasms Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Infantile Spasms Therapeutics Market Size by Type
8.2.1 Asia-Pacific Infantile Spasms Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Infantile Spasms Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Infantile Spasms Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Infantile Spasms Therapeutics Market Size by Application
8.3.1 Asia-Pacific Infantile Spasms Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Infantile Spasms Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Infantile Spasms Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Infantile Spasms Therapeutics Market Size by Region
8.4.1 Asia-Pacific Infantile Spasms Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Infantile Spasms Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Infantile Spasms Therapeutics Market Size (2016-2027)
9.2 Latin America Infantile Spasms Therapeutics Market Size by Type
9.2.1 Latin America Infantile Spasms Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Infantile Spasms Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Infantile Spasms Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Infantile Spasms Therapeutics Market Size by Application
9.3.1 Latin America Infantile Spasms Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Infantile Spasms Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Infantile Spasms Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Infantile Spasms Therapeutics Market Size by Country
9.4.1 Latin America Infantile Spasms Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Infantile Spasms Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infantile Spasms Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Infantile Spasms Therapeutics Market Size by Type
10.2.1 Middle East & Africa Infantile Spasms Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Infantile Spasms Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Infantile Spasms Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Infantile Spasms Therapeutics Market Size by Application
10.3.1 Middle East & Africa Infantile Spasms Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Infantile Spasms Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Infantile Spasms Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Infantile Spasms Therapeutics Market Size by Country
10.4.1 Middle East & Africa Infantile Spasms Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Infantile Spasms Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Mallinckrodt
11.1.1 Mallinckrodt Company Details
11.1.2 Mallinckrodt Business Overview
11.1.3 Mallinckrodt Infantile Spasms Therapeutics Introduction
11.1.4 Mallinckrodt Revenue in Infantile Spasms Therapeutics Business (2016-2021)
11.1.5 Mallinckrodt Recent Development
11.2 H. Lundbeck
11.2.1 H. Lundbeck Company Details
11.2.2 H. Lundbeck Business Overview
11.2.3 H. Lundbeck Infantile Spasms Therapeutics Introduction
11.2.4 H. Lundbeck Revenue in Infantile Spasms Therapeutics Business (2016-2021)
11.2.5 H. Lundbeck Recent Development
11.3 Insys Therapeutics
11.3.1 Insys Therapeutics Company Details
11.3.2 Insys Therapeutics Business Overview
11.3.3 Insys Therapeutics Infantile Spasms Therapeutics Introduction
11.3.4 Insys Therapeutics Revenue in Infantile Spasms Therapeutics Business (2016-2021)
11.3.5 Insys Therapeutics Recent Development
11.4 Orphelia Pharma
11.4.1 Orphelia Pharma Company Details
11.4.2 Orphelia Pharma Business Overview
11.4.3 Orphelia Pharma Infantile Spasms Therapeutics Introduction
11.4.4 Orphelia Pharma Revenue in Infantile Spasms Therapeutics Business (2016-2021)
11.4.5 Orphelia Pharma Recent Development
11.5 Valerion Therapeutics
11.5.1 Valerion Therapeutics Company Details
11.5.2 Valerion Therapeutics Business Overview
11.5.3 Valerion Therapeutics Infantile Spasms Therapeutics Introduction
11.5.4 Valerion Therapeutics Revenue in Infantile Spasms Therapeutics Business (2016-2021)
11.5.5 Valerion Therapeutics Recent Development
11.6 Catalyst Pharmaceuticals
11.6.1 Catalyst Pharmaceuticals Company Details
11.6.2 Catalyst Pharmaceuticals Business Overview
11.6.3 Catalyst Pharmaceuticals Infantile Spasms Therapeutics Introduction
11.6.4 Catalyst Pharmaceuticals Revenue in Infantile Spasms Therapeutics Business (2016-2021)
11.6.5 Catalyst Pharmaceuticals Recent Development
11.7 Anavex Life Sciences
11.7.1 Anavex Life Sciences Company Details
11.7.2 Anavex Life Sciences Business Overview
11.7.3 Anavex Life Sciences Infantile Spasms Therapeutics Introduction
11.7.4 Anavex Life Sciences Revenue in Infantile Spasms Therapeutics Business (2016-2021)
11.7.5 Anavex Life Sciences Recent Development
11.8 Retrophin
11.8.1 Retrophin Company Details
11.8.2 Retrophin Business Overview
11.8.3 Retrophin Infantile Spasms Therapeutics Introduction
11.8.4 Retrophin Revenue in Infantile Spasms Therapeutics Business (2016-2021)
11.8.5 Retrophin Recent Development
11.9 GW Pharmaceuticals
11.9.1 GW Pharmaceuticals Company Details
11.9.2 GW Pharmaceuticals Business Overview
11.9.3 GW Pharmaceuticals Infantile Spasms Therapeutics Introduction
11.9.4 GW Pharmaceuticals Revenue in Infantile Spasms Therapeutics Business (2016-2021)
11.9.5 GW Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Infantile Spasms Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Global Infantile Spasms Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Infantile Spasms Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Infantile Spasms Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Infantile Spasms Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Infantile Spasms Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Infantile Spasms Therapeutics Market Share by Regions (2022-2027)
Table 10. Infantile Spasms Therapeutics Market Trends
Table 11. Infantile Spasms Therapeutics Market Drivers
Table 12. Infantile Spasms Therapeutics Market Challenges
Table 13. Infantile Spasms Therapeutics Market Restraints
Table 14. Global Infantile Spasms Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Infantile Spasms Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Infantile Spasms Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infantile Spasms Therapeutics as of 2020)
Table 17. Ranking of Global Top Infantile Spasms Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Infantile Spasms Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Infantile Spasms Therapeutics Product Solution and Service
Table 21. Date of Enter into Infantile Spasms Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Infantile Spasms Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Infantile Spasms Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Infantile Spasms Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Infantile Spasms Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Infantile Spasms Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Infantile Spasms Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Infantile Spasms Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Infantile Spasms Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Infantile Spasms Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Infantile Spasms Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Infantile Spasms Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Infantile Spasms Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Infantile Spasms Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Infantile Spasms Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Infantile Spasms Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Infantile Spasms Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Infantile Spasms Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Infantile Spasms Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Infantile Spasms Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Infantile Spasms Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Infantile Spasms Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Infantile Spasms Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Infantile Spasms Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Infantile Spasms Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Infantile Spasms Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Infantile Spasms Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Infantile Spasms Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Infantile Spasms Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Infantile Spasms Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Infantile Spasms Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Infantile Spasms Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Infantile Spasms Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Infantile Spasms Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Infantile Spasms Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Infantile Spasms Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Infantile Spasms Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Infantile Spasms Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Infantile Spasms Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Mallinckrodt Company Details
Table 62. Mallinckrodt Business Overview
Table 63. Mallinckrodt Infantile Spasms Therapeutics Product
Table 64. Mallinckrodt Revenue in Infantile Spasms Therapeutics Business (2016-2021) & (US$ Million)
Table 65. Mallinckrodt Recent Development
Table 66. H. Lundbeck Company Details
Table 67. H. Lundbeck Business Overview
Table 68. H. Lundbeck Infantile Spasms Therapeutics Product
Table 69. H. Lundbeck Revenue in Infantile Spasms Therapeutics Business (2016-2021) & (US$ Million)
Table 70. H. Lundbeck Recent Development
Table 71. Insys Therapeutics Company Details
Table 72. Insys Therapeutics Business Overview
Table 73. Insys Therapeutics Infantile Spasms Therapeutics Product
Table 74. Insys Therapeutics Revenue in Infantile Spasms Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Insys Therapeutics Recent Development
Table 76. Orphelia Pharma Company Details
Table 77. Orphelia Pharma Business Overview
Table 78. Orphelia Pharma Infantile Spasms Therapeutics Product
Table 79. Orphelia Pharma Revenue in Infantile Spasms Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Orphelia Pharma Recent Development
Table 81. Valerion Therapeutics Company Details
Table 82. Valerion Therapeutics Business Overview
Table 83. Valerion Therapeutics Infantile Spasms Therapeutics Product
Table 84. Valerion Therapeutics Revenue in Infantile Spasms Therapeutics Business (2016-2021) & (US$ Million)
Table 85. Valerion Therapeutics Recent Development
Table 86. Catalyst Pharmaceuticals Company Details
Table 87. Catalyst Pharmaceuticals Business Overview
Table 88. Catalyst Pharmaceuticals Infantile Spasms Therapeutics Product
Table 89. Catalyst Pharmaceuticals Revenue in Infantile Spasms Therapeutics Business (2016-2021) & (US$ Million)
Table 90. Catalyst Pharmaceuticals Recent Development
Table 91. Anavex Life Sciences Company Details
Table 92. Anavex Life Sciences Business Overview
Table 93. Anavex Life Sciences Infantile Spasms Therapeutics Product
Table 94. Anavex Life Sciences Revenue in Infantile Spasms Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Anavex Life Sciences Recent Development
Table 96. Retrophin Company Details
Table 97. Retrophin Business Overview
Table 98. Retrophin Revenue in Infantile Spasms Therapeutics Business (2016-2021) & (US$ Million)
Table 99. Retrophin Recent Development
Table 100. GW Pharmaceuticals Company Details
Table 101. GW Pharmaceuticals Business Overview
Table 102. GW Pharmaceuticals Infantile Spasms Therapeutics Product
Table 103. GW Pharmaceuticals Revenue in Infantile Spasms Therapeutics Business (2016-2021) & (US$ Million)
Table 104. GW Pharmaceuticals Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Infantile Spasms Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Oral Features
Figure 3. Injection Features
Figure 4. Global Infantile Spasms Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Infantile Spasms Therapeutics Report Years Considered
Figure 8. Global Infantile Spasms Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Infantile Spasms Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Infantile Spasms Therapeutics Market Share by Regions: 2020 VS 2027
Figure 11. Global Infantile Spasms Therapeutics Market Share by Regions (2022-2027)
Figure 12. Global Infantile Spasms Therapeutics Market Share by Players in 2020
Figure 13. Global Top Infantile Spasms Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infantile Spasms Therapeutics as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Infantile Spasms Therapeutics Revenue in 2020
Figure 15. Global Infantile Spasms Therapeutics Revenue Market Share by Type (2016-2021)
Figure 16. Global Infantile Spasms Therapeutics Revenue Market Share by Type (2022-2027)
Figure 17. North America Infantile Spasms Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Infantile Spasms Therapeutics Market Share by Type (2016-2027)
Figure 19. North America Infantile Spasms Therapeutics Market Share by Application (2016-2027)
Figure 20. North America Infantile Spasms Therapeutics Market Share by Country (2016-2027)
Figure 21. United States Infantile Spasms Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Infantile Spasms Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Infantile Spasms Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Infantile Spasms Therapeutics Market Share by Type (2016-2027)
Figure 25. Europe Infantile Spasms Therapeutics Market Share by Application (2016-2027)
Figure 26. Europe Infantile Spasms Therapeutics Market Share by Country (2016-2027)
Figure 27. Germany Infantile Spasms Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Infantile Spasms Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Infantile Spasms Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Infantile Spasms Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Infantile Spasms Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Infantile Spasms Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Infantile Spasms Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Infantile Spasms Therapeutics Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Infantile Spasms Therapeutics Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Infantile Spasms Therapeutics Market Share by Region (2016-2027)
Figure 37. China Infantile Spasms Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Infantile Spasms Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Infantile Spasms Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Infantile Spasms Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Infantile Spasms Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Infantile Spasms Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Infantile Spasms Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Infantile Spasms Therapeutics Market Share by Type (2016-2027)
Figure 45. Latin America Infantile Spasms Therapeutics Market Share by Application (2016-2027)
Figure 46. Latin America Infantile Spasms Therapeutics Market Share by Country (2016-2027)
Figure 47. Mexico Infantile Spasms Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Infantile Spasms Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Infantile Spasms Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Infantile Spasms Therapeutics Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Infantile Spasms Therapeutics Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Infantile Spasms Therapeutics Market Share by Country (2016-2027)
Figure 53. Turkey Infantile Spasms Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Infantile Spasms Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Infantile Spasms Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Mallinckrodt Revenue Growth Rate in Infantile Spasms Therapeutics Business (2016-2021)
Figure 57. H. Lundbeck Revenue Growth Rate in Infantile Spasms Therapeutics Business (2016-2021)
Figure 58. Insys Therapeutics Revenue Growth Rate in Infantile Spasms Therapeutics Business (2016-2021)
Figure 59. Orphelia Pharma Revenue Growth Rate in Infantile Spasms Therapeutics Business (2016-2021)
Figure 60. Valerion Therapeutics Revenue Growth Rate in Infantile Spasms Therapeutics Business (2016-2021)
Figure 61. Catalyst Pharmaceuticals Revenue Growth Rate in Infantile Spasms Therapeutics Business (2016-2021)
Figure 62. Anavex Life Sciences Revenue Growth Rate in Infantile Spasms Therapeutics Business (2016-2021)
Figure 63. Retrophin Revenue Growth Rate in Infantile Spasms Therapeutics Business (2016-2021)
Figure 64. GW Pharmaceuticals Revenue Growth Rate in Infantile Spasms Therapeutics Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
世界の点頭てんかん治療市場規模・現状・予測（2021年-2027年） An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmi…- 世界の小児てんかん治療薬市場規模・現状・予測（2021年-2027年） Epilepsy is one of the most common and challenging neurologic disorders affecting children. Pediatric epilepsies present particular challenges, including correct diagnoses, comorbidities and interactions with developmental processes in the brain. Market Analysis and Insights: Global Pediatric Epilep…
- 世界のポンペ病治療市場規模・現状・予測（2021年-2027年） Pompe disease is a rare disease, also known as acid maltase deficiency (AMD) or glycogen storage disorder (GSD).Glycogenosis II is also called "glycogenosis type 2". The availability of reimbursement policies for the treatment Pompe disease as one of the primary factors that will have a positive imp…
- 世界の口腔粘膜炎治療薬市場規模・現状・予測（2021年-2027年） Oral mucositis (OM) is the inflammation of oral mucosa and is manifested by pain and erythema or ulcerations. This condition is generally seen as a complication due to side effects of chemotherapy and radiotherapy in cancer patients. The systemic effects of cytotoxic chemotherapy agents and radiatio…
- 世界のサンドホフ病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Sandhoff Disease Therapeutics Market The global Sandhoff Disease Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integ…